FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wlodzimierz Buczko

Research Profile

Living Beings

Physiology

Chemicals & Drugs

Anatomy

Disorders

Phenomena

Bleeding Time

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Justyna Magdalena Hermanowicz; Agnieszka Leszczynska; Andrzej Mogielnicki; Anna Tankiewicz-Kwedlo; P Buczko; Adam Hermanowicz; Wlodzimierz Buczko
Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Karol Kramkowski; Agnieszka Leszczynska; Brian Mann; Andrzej Mogielnicki; Roberto Motterlini; Tetsumei Urano; Tomasz Brzoska; Stefan Chlopicki; Andrzej Fedorowicz; Elzbieta Grochal; Wlodzimierz Buczko
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Bartlomiej Kalaska; Kamil Kaminski; Karol Kramkowski; Andrzej Mogielnicki; Maria Nowakowska; Emilia Sokolowska; Krzysztof Szczubialka; Wlodzimierz Buczko
Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wlodzimierz Buczko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Justyna Magdalena Hermanowicz; Agnieszka Leszczynska; Andrzej Mogielnicki; Anna Tankiewicz-Kwedlo; P Buczko; Adam Hermanowicz; Wlodzimierz Buczko
Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Thrombosis research 2013;131(1):e39-44.
2012: Karol Kramkowski; Agnieszka Leszczynska; Brian Mann; Andrzej Mogielnicki; Roberto Motterlini; Tetsumei Urano; Tomasz Brzoska; Stefan Chlopicki; Andrzej Fedorowicz; Elzbieta Grochal; Wlodzimierz Buczko
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(9):2149-57.
2012: Bartlomiej Kalaska; Kamil Kaminski; Karol Kramkowski; Andrzej Mogielnicki; Maria Nowakowska; Emilia Sokolowska; Krzysztof Szczubialka; Wlodzimierz Buczko
Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
European journal of pharmacology 2012;686(1-3):81-9.
2010: Anna Tankiewicz-Kwedlo; Dariusz Pawlak; Tomasz Domaniewski; Wlodzimierz Buczko
Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells.
Pharmacological reports : PR 2010;62(5):926-37.
2010: Karol Kramkowski; Andrzej Mogielnicki; A Leszczynska; Wlodzimierz Buczko
Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2010;61(3):317-24.
2009: L Pietrzak; Andrzej Mogielnicki; Wlodzimierz Buczko
Nicotinamide and its metabolite N-methylnicotinamide increase skin vascular permeability in rats.
Clinical and experimental dermatology 2009;34(3):380-4.
2009: Piotr Myśliwiec; Hanna Myśliwiec; Dariusz Pawlak; Jacek Dadan; Wlodzimierz Buczko; Krystyna Pawlak
[Tryptophan and its metabolites in renal allograft recipients].
Przegla̧d lekarski 2009;66(3):115-8.
2008: Andrzej Mogielnicki; Karol Kramkowski; Justyna M Hermanowicz; Wlodzimierz Buczko
N-methylnicotinamide failed to induce endothelial prostacyclin release in perfused rat hindquarters.
Pharmacological reports : PR 2008;60(6):1025-9.
2008: Iwona Kucharewicz; Anna Bodzenta-Łukaszyk; Wlodzimierz Buczko
Experimental asthma in rats.
Pharmacological reports : PR 2008;60(6):783-8.
2008: Wlodzimierz Buczko; Justyna M Hermanowicz
Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.
Pharmacological reports : PR 2008;60(5):623-31.
2008: Iwona Kucharewicz; Andrzej Mogielnicki; I Kasacka; Wlodzimierz Buczko; A Bodzenta-Łukaszyk
Plasmin system regulation in an ovalbumin-induced rat model of asthma.
International archives of allergy and immunology 2008;147(3):190-6.
2008: Iwona Kucharewicz; Irena Kasacka; Dariusz Pawlak; Anna Tankiewicz-Kwedlo; Barbara Mroczko; Wlodzimierz Buczko; Anna Bodzenta-Lukaszyk
The concentration of kynurenine in rat model of asthma.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2008;46(2):199-203.
2007: Andrzej Mogielnicki; Karol Kramkowski; L Pietrzak; Wlodzimierz Buczko
N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2007;58(3):515-27.
2007: Stefan Chlopicki; Józef Swies; Andrzej Mogielnicki; Wlodzimierz Buczko; M Bartus; Magdalena Lomnicka; Jan Adamus; Jerzy Gebicki
1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
British journal of pharmacology 2007;152(2):230-9.
2007: Janusz Szemraj; Adrian Stankiewicz; Wioletta Rozmyslowicz-Szermińska; Andrzej Mogielnicki; Anna Gromotowicz; Wlodzimierz Buczko; Katarzyna Oszajca; Jacek Bartkowiak; Ewa Chabielska
A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity - a staphylokinase variant. An in-vivo study.
Thrombosis and haemostasis 2007;97(6):1037-45.
2006: Karol Kramkowski; Andrzej Mogielnicki; Wlodzimierz Buczko
The physiological significance of the alternative pathways of angiotensin II production.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2006;57(4):529-39.
2006: M Wojewódzka-Zelezniakowicz; Ewa Chabielska; Andrzej Mogielnicki; Karol Kramkowski; A Karp; A Opadczuk; Tomasz Domaniewski; M Malinowska-Zaprzałka; Wlodzimierz Buczko
Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2006;57(2):231-45.
2006: Wlodzimierz Buczko; Karol Kramkowski; Andrzej Mogielnicki
Are the endothelial mechanisms of ACE-Is already established?
Pharmacological reports : PR 2006;58 Suppl():126-31.
2006: Karol Kramkowski; Andrzej Mogielnicki; Ewa Chabielska; Dorota Cylwik; Wlodzimierz Buczko
The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
Thrombosis research 2006;117(5):557-61.
2005: M Kamińska; Andrzej Mogielnicki; Adrian Stankiewicz; Karol Kramkowski; Tomasz Domaniewski; Wlodzimierz Buczko; Ewa Chabielska
Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2005;56(4):571-85.
2005: Janusz Szemraj; Bogdan Walkowiak; Iwona Kawecka; G Janiszewska; Wlodzimierz Buczko; Jacek Bartkowiak; Ewa Chabielska
A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study.
Journal of thrombosis and haemostasis : JTH 2005;3(10):2156-65.
2005: Andrzej Mogielnicki; Ewa Chabielska; Robert Pawlak; Janusz Szemraj; Wlodzimierz Buczko
Angiotensin II enhances thrombosis development in renovascular hypertensive rats.
Thrombosis and haemostasis 2005;93(6):1069-76.
2005: Halina Ostrowska; Joanna Kalinowska; Ewa Chabielska; Adrian Stankiewicz; Kamil Kruszewski; Wlodzimierz Buczko
Ebelactone B, an inhibitor of extracellular cathepsin A-type enzyme, suppresses platelet aggregation ex vivo in renovascular hypertensive rats.
Journal of cardiovascular pharmacology 2005;45(4):348-53.
2005: Anna Tankiewicz; Dariusz Pawlak; K Pawlak; D Szewc; M Myśliwiec; Wlodzimierz Buczko
Anthranilic acid-uraemic toxin damaged red cell's membrane.
International urology and nephrology 2005;37(3):621-7.
2005: Janusz Szemraj; Khalid N I Al-Nedawi; Ewa Chabielska; Wlodzimierz Buczko; Zofia Pawlowska
Tissue distribution of a menthyl-conjugated oligodeoxyribonucleotide antisense to PAI-1 mRNA.
Acta biochimica Polonica 2005;52(4):849-55.
2005: Wlodzimierz Buczko; Dorota Cylwik; Wanda Stokowska
[Metabolism of tryptophan via the kynurenine pathway in saliva].
Postȩpy higieny i medycyny doświadczalnej (Online) 2005;59():283-9.
2005: Ewa Chabielska; Andrzej Mogielnicki; Karol Kramkowski; Wlodzimierz Buczko
Antithrombotic effect of captopril and enalapril in old rats.
Pharmacological reports : PR 2005;57(1):135-7.
2005: Dorota Cylwik; Andrzej Mogielnicki; Wlodzimierz Buczko
L-arginine and cardiovascular system.
Pharmacological reports : PR 2005;57(1):14-22.
2004: Dorota Cylwik; Andrzej Mogielnicki; Karol Kramkowski; J Stokowski; Wlodzimierz Buczko
Antithrombotic effect of L-arginine in hypertensive rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2004;55(3):563-74.
2004: Justyna K Ostrowska; Marek Z Wojtukiewicz; Ewa Chabielska; Wlodzimierz Buczko; Halina Ostrowska
Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats.
Thrombosis and haemostasis 2004;92(1):171-7.
2004: Sebastian Pawlak; Dariusz Pawlak; Wlodzimierz Buczko
[Hypoxia involvement in erythropoiesis regulation--a new insight].
Przegla̧d lekarski 2004;61(12):1415-9.
2004: Wlodzimierz Buczko; Andrzej Kubik; Iwona Kucharewicz; Ewa Chabielska
Antithrombotic effect of captopril and enalapril in young rats.
Polish journal of pharmacology 2004;56(1):97-104.
2003: Tomasz Matys; Iwona Kucharewicz; Robert Pawlak; Ewa Chabielska; Tomasz Domaniewski; Wlodzimierz Buczko
Nitric oxide-dependent antiplatelet action of AT1-receptor antagonists in a pulmonary thromboembolism in mice.
Journal of cardiovascular pharmacology 2003;42(6):710-3.
2003: Tomasz Wollny; Ewa Chabielska; Małgorzata Malinowska-Zaprzałka; Joanna Nazarko; Wioletta Rozmysłowicz-Szermińska; Wlodzimierz Buczko
Effects of Bulgarian red and white wines on primary hemostasis and experimental thrombosis in rats.
Polish journal of pharmacology 2003;55(6):1089-96.
2003: Wlodzimierz Buczko; Andrzej Mogielnicki; Karol Kramkowski; Ewa Chabielska
Aspirin and the fibrinolytic response.
Thrombosis research 2003;110(5-6):331-4.
2003: Dariusz Pawlak; Anna Tankiewicz; Tomasz Matys; Wlodzimierz Buczko
Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2003;54(2):175-89.
2003: Dariusz Pawlak; Mariusz Koda; Sebastian Pawlak; Slawomir Wolczynski; Wlodzimierz Buczko
Contribution of quinolinic acid in the development of anemia in renal insufficiency.
American journal of physiology. Renal physiology 2003;284(4):F693-700.
2003: Anna Tankiewicz; Dariusz Pawlak; Joanna Topczewska-Bruns; Wlodzimierz Buczko
Kidney and liver kynurenine pathway enzymes in chronic renal failure.
Advances in experimental medicine and biology 2003;527():409-14.
2003: Dariusz Pawlak; Mariusz Koda; Sawomir Wołczyński; Michal Myśliwiec; Wlodzimierz Buczko
Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency.
Advances in experimental medicine and biology 2003;527():375-80.
2003: Joanna Topczewska-Bruns; Dariusz Pawlak; Anna Tankiewicz; Ewa Chabielska; Wlodzimierz Buczko
Kynurenine metabolism in central nervous system in experimental chronic renal failure.
Advances in experimental medicine and biology 2003;527():177-82.
2003: Iwona Kucharewicz; Krzysztof Kowal; Wlodzimierz Buczko; Anna Bodzenta-Łukaszyk
The plasmin system in airway remodeling.
Thrombosis research 2003;112(1-2):1-7.
2002: Iwona Kucharewicz; Robert Pawlak; Tomasz Matys; Ewa Chabielska; Wlodzimierz Buczko
Angiotensin-(1-7): an active member of the renin-angiotensin system.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2002;53(4 Pt 1):533-40.
2002: Iwona Kucharewicz; Robert Pawlak; Tomasz Matys; Dariusz Pawlak; Wlodzimierz Buczko
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
Hypertension 2002;40(5):774-9.
2002: Leszek Kalinowski; Tomasz Matys; Ewa Chabielska; Wlodzimierz Buczko; Tadeusz Malinski
Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
Hypertension 2002;40(4):521-7.
2002: Arsalan Azzadin; Jolanta Małyszko; Jacek S Małyszko; Anna Tankiewicz; Michał Myśliwiec; Wlodzimierz Buczko
Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
Polish journal of pharmacology 2002;54(5):469-73.
2002: Joanna Topczewska-Bruns; Dariusz Pawlak; Ewa Chabielska; Anna Tankiewicz; Wlodzimierz Buczko
Increased levels of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency.
Brain research bulletin 2002;58(4):423-8.
2002: Robert Pawlak; Anna Skrzypiec; Stanislaw Sulkowski; Wlodzimierz Buczko
Ethanol-induced neurotoxicity is counterbalanced by increased cell proliferation in mouse dentate gyrus.
Neuroscience letters 2002;327(2):83-6.
2002: R Zółtowski; Robert Pawlak; Tomasz Matys; M Pietraszek; Wlodzimierz Buczko
Propranolol modifies platelet serotonergic mechanisms in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2002;53(2):265-74.
2002: Piotr Myśliwiec; Dariusz Pawlak; M Myśliwiec; Wlodzimierz Buczko
Endogenous neurotoxine-quinolinic acid is increased in renal allograft recipients.
Transplantation proceedings 2002;34(2):598-600.
2002: Dariusz Pawlak; Anna Tankiewicz; Piotr Mysliwiec; Wlodzimierz Buczko
Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
Nephron 2002;90(3):328-35.
2001: Dariusz Pawlak; Anna Tankiewicz; Wlodzimierz Buczko
Kynurenine and its metabolites in the rat with experimental renal insufficiency.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2001;52(4 Pt 2):755-66.
2001: J Andrzejewska-Buczko; Dariusz Pawlak; Anna Tankiewicz; Tomasz Matys; Wlodzimierz Buczko
Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients.
Medical science monitor : international medical journal of experimental and clinical research 2001;7(4):742-5.
2001: Wlodzimierz Buczko; Tomasz Matys; Robert Pawlak; Iwona Kucharewicz; Ewa Chabielska
Studies on the antithrombotic action of AT1 receptor antagonists.
Medical science monitor : international medical journal of experimental and clinical research 2001;7(4):600-5.
2001: Zofia Pawlowska; Ewa Chabielska; Anna Kobylanska; Anna Maciaszek; Maria Swiatkowska; Wlodzimierz Buczko; Wojciech J Stec; Czeslaw S Cierniewski
Regulation of PAI-1 concentration in platelets by systemic administration of antisense oligonucleotides to rats.
Thrombosis and haemostasis 2001;85(6):1086-9.
2001: Joanna Topczewska-Bruns; Anna Tankiewicz; Dariusz Pawlak; Wlodzimierz Buczko
Behavioral changes in the course of chronic renal insufficiency in rats.
Polish journal of pharmacology 2001;53(3):263-9.
2001: Dariusz Pawlak; K Pawlak; Jolanta Malyszko; Michal Mysliwiec; Wlodzimierz Buczko
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
International urology and nephrology 2001;33(2):399-404.
2001: Anna Tankiewicz; Dariusz Pawlak; Wlodzimierz Buczko
[Enzymes of the kynurenine pathway].
Postȩpy higieny i medycyny doświadczalnej 2001;55(5):715-31.
2001: M Gruszecki; R Rółkowski; Robert Pawlak; Wlodzimierz Buczko
Propranolol prevents the development of venous thrombosis in rats by a platelet-dependent mechanism.
Polish journal of pharmacology 2001;53(1):5-10.
2001: Irena Kasacka; Arsalan Azzadin; Boguslaw Sawicki; Jacek Dadan; H Malla; Wlodzimierz Buczko
Preliminary evaluation of gastric endocrine cells in rats with experimental uremia.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):207-8.
2001: Arsalan Azzadin; Irena Kasacka; Boguslaw Sawicki; H Malla; Jacek Dadan; Wlodzimierz Buczko
Preliminary evaluation of neuroendocrine cells in the respiratory tract in rats with experimental uremia.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):205-6.
2001: Arsalan Azzadin; Irena Kasacka; Boguslaw Sawicki; Jacek Dadan; H Malla; Wlodzimierz Buczko
Preliminary evaluation of thyroid C cells in rats with chronic renal failure.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):203-4.
2001: Boguslaw Sawicki; Irena Kasacka; Arsalan Azzadin; Jacek Dadan; H Malla; Cezary Nowosielski; Wlodzimierz Buczko; W Niklińska
Preliminary evaluation of endocrine cells in the rat respiratory tract after thyroid and parathyroid gland removal.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):193-4.
2000: S Chłopicki; M Koda; E Chabielska; Wlodzimierz Buczko; Ryszard J Gryglewski
Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2000;51(4 Pt 1):715-22.
2000: Tomasz Matys; Ewa Chabielska; Robert Pawlak; Iwona Kucharewicz; Wlodzimierz Buczko
Losartan inhibits the adhesion of rat platelets to fibrillar collagen--a potential role of nitric oxide and prostanoids.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2000;51(4 Pt 1):705-13.
2000: Robert Pawlak; Ewa Chabielska; Tomasz Matys; Iwona Kucharewicz; Wlodzimierz Buczko
The role of the thiol group in the antithrombotic action of captopril.
Thrombosis and haemostasis 2000;84(5):919-20.
2000: Robert Pawlak; Ewa Chabielska; Tomasz Matys; Iwona Kucharewicz; R Rółkowski; Wlodzimierz Buczko
Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.
Journal of cardiovascular pharmacology 2000;36(4):503-9.
2000: Iwona Kucharewicz; Ewa Chabielska; Dariusz Pawlak; Tomasz Matys; R Rólkowski; Wlodzimierz Buczko
The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(3):268-72.
2000: Ewa Chabielska; Tomasz Matys; Iwona Kucharewicz; Dariusz Pawlak; R Rólkowski; Wlodzimierz Buczko
The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(3):263-7.
2000: Dariusz Pawlak; E Malczyk; Janusz S Darewicz; Arsalan Azzadin; Wlodzimierz Buczko
Platelet serotonergic mechanisms in patients with cancer of the urinary bladder.
Thrombosis research 2000;98(5):367-74.
2000: J S Małyszko; J Małyszko; Krystyna Pawlak; D Pawlak; Wlodzimierz Buczko; M Myśliwiec
Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
Nephron 2000;84(4):305-11.
2000: Wlodzimierz Buczko; Iwona Kucharewicz
Angiotensin-(1-7). One step forward?
Polish journal of pharmacology 2000;52(2):75-81.
2000: D Napiórkowska-Pawlak; Barbara Malinowska; Robert Pawlak; Wlodzimierz Buczko; Manfred Göthert
Attenuation of the acute amnestic effect of ethanol by ifenprodil: comparison with ondansetron and dizocilpine.
Fundamental & clinical pharmacology 2000;14(2):125-31.
2000: Tomasz Matys; Robert Pawlak; Iwona Kucharewicz; Ewa Chabielska; Wlodzimierz Buczko
Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2000;51(1):161-6.
1999: Wlodzimierz Buczko; Tomasz Matys; Iwona Kucharewicz; Ewa Chabielska
The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1999;50(4):499-507.
1999: Barbara Malinowska; D Napiórkowska-Pawlak; Robert Pawlak; Wlodzimierz Buczko; Manfred Göthert
Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration.
European journal of pharmacology 1999;377(1):13-9.
1999: Ewa Chabielska; Robert Pawlak; Tomasz Wollny; R Rółkowski; Wlodzimierz Buczko
Antithrombotic activity of losartan in two kidney, one clip hypertensive rats. A study on the mechanism of action.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1999;50(1):99-109.
1999: E Malczyk; Barbara Darewicz; Dariusz Pawlak; Janusz S Darewicz; Wlodzimierz Buczko
Investigations of urinary lead concentration in patients with urinary bladder carcinoma.
International urology and nephrology 1999;31(5):661-3.
1999: Arsalan Azzadin; Tomasz Wollny; Robert Pawlak; J S Malyszko; Jolanta Malyszko; M Myśliwiec; Wlodzimierz Buczko
L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
Nephron 1999;83(4):370-1.
1998: Jacek S Malyszko; J Malyszko; Dariusz Pawlak; Wlodzimierz Buczko; M Myśliwiec
Hemostasis, platelet functions, serotonin and serum lipids during omega-3 fatty acid treatment in patients with glomerulonephritis.
Nephron 1998;80(1):94-6.
1998: Ewa Chabielska; Robert Pawlak; J Golatowski; R Rółkowski; Dariusz Pawlak; Wlodzimierz Buczko
Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats.
Thrombosis research 1998;90(6):271-8.
1998: Dariusz Pawlak; K Pawlak; Ewa Chabielska; J Małyszko; A Takada; M Myśliwiec; Wlodzimierz Buczko
A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats.
Thrombosis research 1998;90(6):259-70.
1998: Arsalan Azzadin; Wlodzimierz Buczko
[Erythropoietin and hypertension].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 1998;4(24):295-7.
1998: Ewa Chabielska; Robert Pawlak; J Golatowski; Wlodzimierz Buczko
The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1998;49(2):251-60.
1998: Robert Pawlak; Ewa Chabielska; J Golatowski; Arsalan Azzadin; Wlodzimierz Buczko
Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Thrombosis and haemostasis 1998;79(6):1208-12.
1998: Jacek Borawski; A Rydzewski; Krystyna Pawlak; Arsalan Azzadin; Wlodzimierz Buczko; Michal Mysliwiec
Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
Thrombosis research 1998;90(4):171-80.
1998: Zofia Pawlowska; E Pluskota; Ewa Chabielska; Wlodzimierz Buczko; Andrzej Okruszek; Wojciech J Stec; Czeslaw S Cierniewski
Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
Thrombosis and haemostasis 1998;79(2):348-53.
1998: Jacek Borawski; A Rydzewski; Arsalan Azzadin; Wlodzimierz Buczko; Michal Mysliwiec
Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies.
Platelets 1998;9(1):31-5.
1997: Wlodzimierz Buczko; Czeslaw S Cierniewski; A Kobylańska; M Koziołkiewicz; Andrzej Okruszek; Z Pawłowska; E Pluskota; Wojciech J Stec
Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs.
Pharmacology & therapeutics 1997;76(1-3):161-75.
1997: Tomasz Wollny; Licia Iacoviello; Wlodzimierz Buczko; Giovanni de Gaetano; Maria Benedetta Donati
Prolongation of bleeding time by acute hemolysis in rats: a role for nitric oxide.
The American journal of physiology 1997;272(6 Pt 2):H2875-84.
1997: A Rydzewski; J Małyszko; Jacek Borawski; Dariusz Pawlak; Arsalan Azzadin; Wlodzimierz Buczko; M Myśliwiec
Altered circadian rhythm of platelet aggregation in hemodialyzed patients.
Nephron 1997;77(3):365-7.
1997: A Rydzewski; J Małyszko; Jacek Borawski; Dariusz Pawlak; K Adamcewicz; Wlodzimierz Buczko; M Myśliwiec
[Altered circadian rhythm of platelet aggregation in patients on longterm hemodialysis].
Przegla̧d lekarski 1997;54(3):167-70.
1996: Dariusz Pawlak; Barbara Malinowska; T Wollny; G Godlewski; Wlodzimierz Buczko
Lack of the specific influence of histamine and histamine H1, H2 and H3 receptor ligands on the serotonin uptake and release in rat blood platelets.
Polish journal of pharmacology 1996;48(6):615-20.
1996: J Malyszko; Jacek S Malyszko; Dariusz Pawlak; K Pawlak; Wlodzimierz Buczko; Michal Mysliwiec
Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Thrombosis research 1996;83(5):351-61.
1996: Dariusz Pawlak; J Malyszko; Jacek S Malyszko; K Pawlak; Wlodzimierz Buczko; Michal Mysliwiec
Peripheral serotonergic system in uremia.
Thrombosis research 1996;83(2):189-94.
1996: J Mysliwiec; Arsalan Azzadin; Ewa Chabielska; A Takada; Michal Mysliwiec; Wlodzimierz Buczko
The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.
Thrombosis research 1996;83(2):175-81.
1996: J Malyszko; Dariusz Pawlak; K Pawlak; Jacek S Malyszko; Wlodzimierz Buczko; A Azzudin; Michal Mysliwiec
Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
Transplantation proceedings 1996;28(3):1954-7.
1996: D Krygicz; Arsalan Azzadin; Robert Pawlak; J S Małyszko; Dariusz Pawlak; M Myśliwiec; Wlodzimierz Buczko
Cyclosporine A affects serotonergic mechanisms in uremic rats.
Polish journal of pharmacology 1996;48(3):351-4.
1996: J Małyszko; J S Małyszko; Dariusz Pawlak; K Pawlak; A Rydzewski; M Myśliwiec; Wlodzimierz Buczko
Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
Polish journal of pharmacology 1996;48(2):191-5.
1996: M Pietraszek; Ewa Chabielska; Arsalan Azzadin; Robert Pawlak; Wlodzimierz Buczko
Effect of endothelin-1 on some hemostatic parameters in normotensive rats.
Acta physiologica Hungarica 1996;84(3):329-30.
1996: Robert Pawlak; Ewa Chabielska; R Rółkowski; Wlodzimierz Buczko
Influence of captopril on some haemostatic parameters in rats with ongoing process of venous thrombosis.
Acta physiologica Hungarica 1996;84(3):327-8.
1996: Dariusz Pawlak; J Małyszko; M Myśliwiec; A Takada; Wlodzimierz Buczko
Effect of DV-7028, a novel serotonin 5-HT2 receptor antagonist on the cardiovascular system in rats.
Acta physiologica Hungarica 1996;84(3):325-6.
1996: Dariusz Pawlak; J Małyszko; M Myśliwiec; A Takada; Wlodzimierz Buczko
Influence of MCI-9042, a novel 5-HT2 receptor blocker on blood vessels of the rat.
Acta physiologica Hungarica 1996;84(3):323-4.
1996: Ewa Chabielska; Robert Pawlak; Wlodzimierz Buczko
Losartan does not influence the blood platelet aggregation in normotensive rats.
Acta physiologica Hungarica 1996;84(3):271-2.
1996: Robert Pawlak; Ewa Chabielska; Wlodzimierz Buczko
Antithrombotic effect of enalapril, an angiotensin-converting enzyme inhibitor, on venous thrombosis in rats.
Polish journal of pharmacology 1996;48(1):117-20.
1996: Ewa Chabielska; Robert Pawlak; Wlodzimierz Buczko
Effects of drugs affecting the renin-angiotensin system on venous thrombosis in normotensive rats.
Polish journal of pharmacology 1996;48(1):89-91.
1996: Arsalan Azzadin; J Malyszko; Jacek S Malyszko; Wlodzimierz Buczko; Michal Mysliwiec
Correlation between serotonin concentration and blood pressure in kidney transplant recipients treated with cyclosporine.
Nephron 1996;72(2):336-7.
1995: D Morelowska-Spierzak; Dariusz Pawlak; Wlodzimierz Buczko
Influence of captopril on the serotonin-induced vasopressor effect in tail artery isolated from two-kidney, one-clip renal hypertensive rats.
Polish journal of pharmacology 1995;47(5):417-22.
1995: Arsalan Azzadin; J Mysliwiec; Tomasz Wollny; Michal Mysliwiec; Wlodzimierz Buczko
Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats.
Thrombosis research 1995;77(3):217-24.
1995: J Malyszko; Jacek S Malyszko; Jacek Borawski; A Rydzewski; M Kalinowski; Arsalan Azzadin; Michal Mysliwiec; Wlodzimierz Buczko
A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
Thrombosis research 1995;77(2):133-43.
1995: Jacek S Malyszko; J Malyszko; Arsalan Azzadin; Wlodzimierz Buczko; Michal Mysliwiec
Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
Thrombosis and haemostasis 1995;73(1):164-5.
1993: Dariusz Pawlak; D Morelowska-Spierzak; Arsalan Azzadin; K Wróbel; Wlodzimierz Buczko
Lack of effect of acetaldehyde on the cardiovascular system in rats.
Alcohol and alcoholism (Oxford, Oxfordshire) 1993;28(5):529-33.
1993: J Małyszko; J Małyszko; M Pietraszek; Arsalan Azzadin; M Myśliwiec; Wlodzimierz Buczko
[Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
Polskie Archiwum Medycyny Wewnętrznej 1993;90(2):105-11.
1993: J Malyszko; M Mazerska; J Malyszko; K Pawlak; Arsalan Azzadin; Michal Mysliwiec; Wlodzimierz Buczko
Serotonergic mechanisms are involved in the hemostatic action of erythropoietin in uremic patients.
International journal of clinical & laboratory research 1993;23(1):42-4.
1993: Dariusz Pawlak; Ewa Chabielska; Wlodzimierz Buczko
Influence of acetaldehyde on some serotonergic mechanisms in rat blood platelets.
Polish journal of pharmacology 1993;45(1):59-66.
1993: Wlodzimierz Buczko; Barbara Malinowska; M H Pietraszek; Dariusz Pawlak; Ewa Chabielska
Influence of Tołpa Peat Preparation on haemostasis in rats.
Acta poloniae pharmaceutica 1993;50(6):507-11.
1992: M Pietraszek; Arsalan Azzadin; Wlodzimierz Buczko; J Malyszko; Michal Mysliwiec
A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
Thrombosis and haemostasis 1992;68(5):625.
1992: J Malyszko; Jacek S Malyszko; Arsalan Azzadin; Michal Mysliwiec; Wlodzimierz Buczko
DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
Thrombosis research 1992;68(3):303-8.
1992: M Mazerska; K Pawlak; Arsalan Azzadin; J Małyszko; J Małyszko; M Myśliwiec; Wlodzimierz Buczko
[Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia].
Polskie Archiwum Medycyny Wewnętrznej 1992;88(4):230-7.
1992: Barbara Malinowska; Dariusz Pawlak; Wlodzimierz Buczko
Influence of DAU 6215, a novel 5-HT3 receptor antagonist, on the cardiovascular system in anaesthetized and pithed rats.
Agents and actions 1992;36(3-4):230-6.
1992: Dariusz Pawlak; D Krygicz; Ewa Chabielska; Wlodzimierz Buczko
Influence of acetaldehyde on the vasopressor effect of serotonin in pithed rats.
Alcohol and alcoholism (Oxford, Oxfordshire) 1992;27(4):367-72.
1992: D Morelowska; Ewa Chabielska; Dariusz Pawlak; Arsalan Azzadin; A Białkowska; D Krygicz; Wlodzimierz Buczko
Effect of captopril on serotonergic mechanisms in two-kidney, one-clip renal hypertensive rats.
Polish journal of pharmacology and pharmacy 1992;44(4):365-72.
1992: Arsalan Azzadin; A Bialkowska; Dariusz Pawlak; Ewa Chabielska; M Mazerska; Michal Mysliwiec; Wlodzimierz Buczko
Serotonin is involved in some effects of erythropoietin.
Thrombosis research 1992;65(4-5):657-61.
1992: Dariusz Pawlak; Barbara Malinowska; Wlodzimierz Buczko
Cardiovascular effects of acetaldehyde in pithed rats.
Pharmacology 1992;45(2):83-9.
1992: M Pietraszek; J Malyszko; Arsalan Azzadin; J Malyszko; Wlodzimierz Buczko; Michal Mysliwiec
Serotonin and hypertension in uraemia: a possible link?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(9):980-1.
1992: Arsalan Azzadin; A Bialkowska; Wlodzimierz Buczko; J Malyszko; M Kalinowski; Michal Mysliwiec
Serotonergic mechanism of erythropoietin-induced hypertension.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7(8):882-3.
1990: Arsalan Azzadin; M H Pietraszek; Wlodzimierz Buczko
Effects of verapamil on some parameters of haemostasis in rats with experimental chronic renal failure.
Thrombosis research 1990;60(1):99-103.
1990: Barbara Malinowska; M Pietraszek; Ewa Chabielska; Dariusz Pawlak; Wlodzimierz Buczko
The effect of ethanol and serotonin on blood vessels of the rat.
Polish journal of pharmacology and pharmacy 1990;42(4):333-42.
1990: Ewa Chabielska; Barbara Malinowska; Wlodzimierz Buczko
Influence of ethanol and serotonin on rat platelet aggregation.
Pharmacology 1990;40(5):288-92.
1990: Barbara Malinowska; Dariusz Pawlak; Ewa Chabielska; Wlodzimierz Buczko
Influence of acute and chronic ethanol administration on the vasopressor effect of serotonin in pithed rats.
Pharmacology 1990;41(2):91-7.
1990: Barbara Malinowska; Ewa Chabielska; M H Pietraszek; Wlodzimierz Buczko
The serotonergic mechanisms are not involved in the inhibitory effect of captopril on rat platelet aggregation.
Haemostasis 1990;20(1):48-53.
1990: J Malyszko; M Pietraszek; Wlodzimierz Buczko; Michal Mysliwiec
Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
Folia haematologica (Leipzig, Germany : 1928) 1990;117(2):319-24.
1989: Barbara Malinowska; Dariusz Pawlak; Ewa Chabielska; Wlodzimierz Buczko
Cardiovascular effects of ethanol in anaesthetized, conscious and pithed rats.
Drug and alcohol dependence 1989;24(1):51-6.
1989: Barbara Malinowska; M Pietraszek; Ewa Chabielska; Wlodzimierz Buczko
The influence of propranolol on the hypotensive action of ketanserin in normotensive rats.
Acta physiologica Polonica 1989;40(4):356-62.
1989: J Małyszko; M H Pietraszek; Arsalan Azzadin; Wlodzimierz Buczko; M Myśliwiec
Desmopressin induces decrease in platelet serotonin content in uremia.
Thrombosis and haemostasis 1989;61(3):537.
1989: M Konopelko; Barbara Malinowska; Ewa Chabielska; Wlodzimierz Buczko
[Effect of Polfos on the bleeding time. II. Changes in selected parameters of the blood coagulation system and fibrinolysis].
Medycyna pracy 1989;40(2):80-4.
1989: Barbara Malinowska; Wlodzimierz Buczko
Influence of captopril on the vasopressor effect of serotonin in pithed rats.
Pharmacology 1989;38(5):273-8.
1989: M Konopelko; Barbara Malinowska; Ewa Chabielska; Wlodzimierz Buczko
[Effect of Polfos on the bleeding time. III. Changes in various parameters of the circulatory system].
Medycyna pracy 1989;40(3):147-52.
1988: Ewa Chabielska; M Pietraszek; Barbara Malinowska; Wlodzimierz Buczko
The effect of ethanol on some serotonergic mechanisms in rat blood platelets.
Polish journal of pharmacology and pharmacy 1988;40(3):241-9.
1988: M H Pietraszek; Ewa Chabielska; Wlodzimierz Buczko
Effects of verapamil, diltiazem and nifedipine on some parameters of hemostasis in the rat.
Thrombosis research 1988;50(2):325-8.
1988: M Konopelko; Barbara Malinowska; Ewa Chabielska; Wlodzimierz Buczko
[Effect of Polfos on bleeding time. I. Changes in the formed elements of the blood in rats exposed to Polfos].
Medycyna pracy 1988;39(6):391-8.
1988: M Pietraszek; Ewa Chabielska; Barbara Malinowska; Wlodzimierz Buczko
The effect of verapamil on serotonergic mechanisms in the rat blood platelets.
Polish journal of pharmacology and pharmacy 1988;40(1):81-6.